The main application for the MegaPlex technology developed by University of Leicester researchers, is in medium scale genomic analysis (such as targeted Next Generation Sequencing, high-plex genotyping, and sample identification/fingerprinting) in areas such as biomedical research, clinical diagnostics, agricultural/livestock quality control, and environmental monitoring. These are all large markets, for example the in vitro diagnostics market is expected to reach $16.38Bn globally, with rapid growth between 2013 to 2023, with molecular diagnostics already representing 18% of the >$10Bn IVD market in Europe alone in 2014.
